We recently introduced our new team member Carlos Pigotti as we were approaching Clinical Trials Day. To keep the celebration of research going, we are excited to share a little more about Carlos’ experience, his passion for clinical research and process optimization, and his views for the future.
Hi, Carlos! Let's start by discussing your background in the industry and the roles you've held. Could you share a bit about that?
Certainly! I have three years of experience in the clinical research industry. It all began with my role as a molecular biologist co-op at Fox Chase Cancer Center, where I focused on studying the anti-tumorigenic effects of various molecular compounds in mouse models. Following that, I worked as a clinical research coordinator for different companies, specializing in Ophthalmology, Neuro-Ophthalmology, and Oncology.
Coming from the industry, what inspired you to join the Slope team?
I'm genuinely passionate about research and process optimization. As a clinical research coordinator, I noticed a lack of online solutions commonly used in other industries within the clinical research field. That's precisely what motivated me to join Slope. The company is dedicated to solving problems and optimizing a crucial aspect of the clinical research industry—the supply chain. By doing so, Slope has the potential to enhance the overall experience of participating in a clinical trial for both large organizations like CROs and research sites, as well as individual patients. I find that incredibly exciting.
What were your expectations when joining the Slope team, and what has surprised you about working here?
Transitioning to a fully remote position was uncharted territory for me, so I wasn't entirely sure what to expect. However, I've been pleasantly surprised by the dynamic nature of my role at Slope. It's far more engaging and varied than I had imagined, and I've been learning a great deal. Additionally, I've been enjoying the company culture, which fosters a relaxed and supportive environment. It's a refreshing change from the more traditional atmosphere of a research site.
Being a part of the Slope team, what has been your favorite aspect? And how would you define the idea of "getting Sloped”?
My favorite part is the feeling of being part of a team that shares clear goals and possesses the drive to achieve them while enjoying the journey. It's incredibly rewarding.
To me, "getting Sloped" signifies a gradual and pleasant progression of understanding that something or someone holds more value and meaning than initially assumed. It's about gaining familiarity and realizing the significance beyond any preconceived notions. Just like ascending a slope, each step reveals a broader view from the mountaintop.
We'd love to hear your perspective on the state of the clinical trials industry. What notable changes have you witnessed since the start of your career? What aspects have remained unchanged? And where do you envision the future of clinical trials?
In my experience, certain aspects of the clinical trial industry seem to have remained stagnant. Many essential processes crucial for conducting clinical trials are still performed manually or semi-manually. However, I believe that positive change is on the horizon, especially with the emergence of tools like Slope. I foresee increased automation in patient screening, enrollment, and management in the near future. Additionally, seamless data integration between platforms will play a critical role in advancing clinical research. These advancements will not only streamline and enhance the efficiency of clinical trials but also lead to improved patient experiences and outcomes.
In case you missed it, here was the Q&A with another Slope team member, Gabrielle Jones.